期刊文献+

CD271 as a marker to identify mesenchymal stem cells from diverse sources before culture 被引量:4

CD271 as a marker to identify mesenchymal stem cells from diverse sources before culture
下载PDF
导出
摘要 Mesenchymal stem cells, due to their characteristics are ideal candidates for cellular therapy. Currently, in culture these cells are defined by their adherence to plastic, specific surface antigen expression and multipotent differentiation potential. However, the in vivo identification of mesenchymal stem cells, before culture, is not so well established. Pre-culture identification markers would ensure higher purity than that obtained with selection based on adherence to plastic. Up until now, CD271 has been described as the most specific marker for the characterization andpurification of human bone marrow mesenchymal stem cells. This marker has been shown to be specifically expressed by these cells. Thus, CD271 has been proposed as a versatile marker to selectively isolated and expand multipotent mesenchymal stem cells with both immunosuppressive and lymphohematopoietic engraftment-promoting properties. This review focuses on this marker, specifically on identification of mesenchymal stem cells from different tissues. Literature revision suggests that CD271 should not be defined as a universal marker to identify mesenchymal stem cells before culture from different sources. In the case of bone marrow or adipose tissue, CD271 could be considered a quite suitable marker; however this marker seems to be inadequate for the isolation of mesenchymal stem cells from other tissues such as umbilical cord blood or wharton's jelly among others. Mesenchymal stem cells, due to their characteristicsare ideal candidates for cellular therapy. Currently,in culture these cells are defined by their adherenceto plastic, specific surface antigen expression andmultipotent differentiation potential. However, thein vivo identification of mesenchymal stem cells,before culture, is not so well established. Pre-cultureidentification markers would ensure higher purity thanthat obtained with selection based on adherence toplastic. Up until now, CD271 has been described asthe most specific marker for the characterization andpurification of human bone marrow mesenchymal stemcells. This marker has been shown to be specificallyexpressed by these cells. Thus, CD271 has beenproposed as a versatile marker to selectively isolatedand expand multipotent mesenchymal stem cells withboth immunosuppressive and lymphohematopoieticengraftment-promoting properties. This reviewfocuses on this marker, specifically on identificationof mesenchymal stem cells from different tissues.Literature revision suggests that CD271 should not bedefined as a universal marker to identify mesenchymalstem cells before culture from different sources. In thecase of bone marrow or adipose tissue, CD271 couldbe considered a quite suitable marker; however thismarker seems to be inadequate for the isolation ofmesenchymal stem cells from other tissues such asumbilical cord blood or wharton's jelly among others.
机构地区 Unidad de Trasplantes
出处 《World Journal of Stem Cells》 SCIE CAS 2015年第2期470-476,共7页 世界干细胞杂志(英文版)(电子版)
关键词 MESENCHYMAL stem cells CD271 Lowaffinitynerve growth factor receptor P75 Bone MARROW Mesenchymal stem cells CD271 Lowaffinity nerve growth factor receptor p75 Bone marrow
  • 相关文献

参考文献62

  • 1Farini A, Sitzia C, Erratico S, Meregalli M, Torrente Y. Clinicalapplications of mesenchymal stem cells in chronic diseases.Stem Cells Int 2014; 2014: 306573 [PMID: 24876848 DOI:10.1155/2014/306573]. 被引量:1
  • 2Piku-a M, Marek-Trzonkowska N, Wardowska A, RenkielskaA, Trzonkowski P. Adipose tissue-derived stem cells in clinicalapplications. Expert Opin Biol Ther 2013; 13: 1357-1370 [PMID:23919743 DOI: 10.1517/14712598.2013.823153]. 被引量:1
  • 3Chan TM, Harn HJ, Lin HP, Chou PW, Chen JY, Ho TJ, ChiouTW, Chuang HM, Chiu SC, Chen YC, Yen SY, Huang MH, LiangBC, Lin SZ. Improved human mesenchymal stem cell isolation.Cell Transplant 2014; 23: 399-406 [PMID: 24816441 DOI: 10.3727/096368914X678292]. 被引量:1
  • 4Das M, Sundell IB, Koka PS. Adult mesenchymal stem cells andtheir potency in the cell-based therapy. J Stem Cells 2013; 8: 1-16[PMID: 24459809]. 被引量:1
  • 5Dorronsoro A, Fernández-Rueda J, Fechter K, Ferrin I, SalcedoJM, Jakobsson E, Trigueros C. Human mesenchymal stromal cellmediatedimmunoregulation: mechanisms of action and clinicalapplications. Bone Marrow Res 2013; 2013: 203643 [PMID:24187625 DOI: 10.1155/2013/203643]. 被引量:1
  • 6Bieback K. Platelet lysate as replacement for fetal bovine serum inmesenchymal stromal cell cultures. Transfus Med Hemother 2013;40: 326-335 [PMID: 24273486 DOI: 10.1159/000354061]. 被引量:1
  • 7Friedenstein AJ, Chailakhjan RK, Lalykina KS. The developmentof fibroblast colonies in monolayer cultures of guinea-pig bonemarrow and spleen cells. Cell Tissue Kinet 1970; 3: 393-403 [PMID:5523063]. 被引量:1
  • 8Boxall SA, Jones E. Markers for characterization of bone marrowmultipotential stromal cells. Stem Cells Int 2012; 2012: 975871[PMID: 22666272 DOI: 10.1155/2012/975871]. 被引量:1
  • 9Bianco P, Robey PG, Simmons PJ. Mesenchymal stem cells:revisiting history, concepts, and assays. Cell Stem Cell 2008; 2:313-319 [PMID: 18397751 DOI: 10.1016/j.stem.2008.03.002]. 被引量:1
  • 10Rastegar F, Shenaq D, Huang J, Zhang W, Zhang BQ, He BC,Chen L, Zuo GW, Luo Q, Shi Q, Wagner ER, Huang E, Gao Y, GaoJL, Kim SH, Zhou JZ, Bi Y, Su Y, Zhu G, Luo J, Luo X, Qin J, ReidRR, Luu HH, Haydon RC, Deng ZL, He TC. Mesenchymal stemcells: Molecular characteristics and clinical applications. World JStem Cells 2010; 2: 67-80 [PMID: 21607123 DOI: 10.4252/wjsc.v2.i4.67]. 被引量:1

同被引文献17

引证文献4

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部